Vera Therapeutics Inc (VERA) Stock Analysis

Vera Therapeutics Inc (VERA) is a publicly traded company in the HEALTHCARE sector. It trades at $31.26, carries a market capitalization of $2.44B. This page summarizes the public market data, fundamentals, and frequently asked questions for VERA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Vera Therapeutics Inc currently has a Neutral sentiment score of 0.08.

About Vera Therapeutics Inc

Vera Therapeutics Inc. is a clinical-stage biotechnology company based in South San Francisco, California, specializing in the development of innovative therapies for serious immune-mediated diseases. Committed to addressing significant unmet medical needs, Vera's pipeline includes promising candidates designed to enhance patient outcomes and quality of life. With a focus on cutting-edge immunology, the company is well-positioned to lead advancements in therapeutic strategies that could trans...

GNG Research Analysis

GNG Research scores Vera Therapeutics Inc (VERA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VERA.

Frequently Asked Questions

Does VERA pay dividends?

Vera Therapeutics Inc (VERA) does not currently pay a regular dividend.

What is VERA's market cap?

Vera Therapeutics Inc (VERA) has a market capitalization of $2.44B with a current stock price of $31.26.